← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Sep 30, 2018
Defunct as of Mar 31, 2014
Timeline
2000s
- Jun 1, 2005
Lux Biosciences, Inc.— Founded
2010s
- Mar 31, 2014
Lux Biosciences, Inc.— Defunct
Drugs by trial phase (5 distinct, 8 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT03659201CollaboratorPhase 4Sep 30, 2018
- NCT01243983Lead sponsorPhase 3Feb 1, 2011
- NCT00851734Lead sponsorPhase 1Feb 1, 2009
- NCT00447642Study chairPhase 3Apr 1, 2007
- NCT00447187Lead sponsorPhase 3Apr 1, 2007
- NCT00447187Study chairPhase 3Apr 1, 2007
- NCT00447642Lead sponsorPhase 3Apr 1, 2007
- NCT00404612Lead sponsorPhase 3Jan 1, 2007
- NCT00404885Lead sponsorPhase 3Jan 1, 2007
- NCT00404742Lead sponsorPhase 3Jan 1, 2007
Details
- Founded
- Jersey City, NJ, US Jun 1, 2005
- Last known activity
- Sep 30, 2018
Notes
No evidence company exists after termination of license in 2014 https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=7&cad=rja&uact=8&ved=2ahUKEwju3c73t4ziAhUMY6wKHSxNAtcQFjAGegQIAhAC&url=https%3A%2F%2Fd1io3yog0oux5.cloudfront.net%2F_35f8038bdd85aa64c17be849c56f748c%2Fauriniapharma%2Fdb%2F267%2F735%2Fannual_information_form%2FAIFDecember312013.pdf&usg=AOvVaw2iO60vLkaLEeWP3Qj6Xm97